Skip to main content
AUVI logo

Applied UV, Inc. (AUVI) Stock Price & Analysis

Educational signal · not a buy or sell recommendation · How to read this

$0.0001 $0.00 (0.00%)
Vol: 1.2K| 52-wk range: $0.0001 – $0.002
Data from FMP · Methodology

For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.5-flash, generated Jun 15, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR

Quick Answer

Applied UV, Inc. (AUVI) trades at $0.0001. Applied UV, Inc. develops and commercializes air purification and infection control technologies, alongside manufacturing decorative mirrors and bathroom vanities. Sector: Consumer discretionary.

Price as of · Last analyzed: Jun 15, 2026
Applied UV, Inc. develops and commercializes air purification and infection control technologies, alongside manufacturing decorative mirrors and bathroom vanities. The company serves healthcare, hospitality, commercial, municipal, and residential markets across the United States, Canada, and Europe.

Analyst Coverage for AUVI: AUVI does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.

▶ Watch the AUVI film Every key number, told as a short cinematic story — just press play. ~2 min

No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.

Applied UV, Inc. (AUVI) Consumer Business Overview

CEOMax Munn
Employees131
HeadquartersMount Vernon, US
IPO Year2020

Applied UV, Inc. operates in the Consumer Cyclical sector, specializing in science-based air purification and hard surface disinfection solutions under brands like Airocide and Lumicide. Concurrently, it maintains a presence in the hospitality market through decorative mirrors and bathroom vanities, serving diverse markets across North America and Europe.

Data Provenance | Financial Data Quantitative Analysis Analysis: Jun 15, 2026

What Is the Investment Thesis for AUVI?

AI-written as of Jun 15, 2026 — figures and tone reflect the data available then, not today's score.

Applied UV, Inc. presents a unique market position by combining infection control technologies with a hospitality furnishings segment, operating across the U.S., Canada, and Europe. The company's focus on science-based solutions under brands like Airocide and Lumicide positions it within growing markets for health and safety, particularly relevant in healthcare and commercial sectors. However, the company currently operates with a significant negative profit margin of -32.4% and a gross margin of 19.2%, indicating challenges in achieving profitability despite its market presence. The reported market capitalization of $0.00B suggests a very small or negligible public valuation, which implies substantial financial risk and potential liquidity concerns. Future growth catalysts could stem from increased adoption of its disinfection technologies in response to public health demands and potential expansion within the hospitality sector as travel and leisure recover. The company's negative Beta of -1.10 is unusual and could suggest an inverse correlation to market movements or reflect low trading volume and volatility, warranting careful consideration for investors evaluating market risk exposure. The company's ability to scale its operations, improve cost efficiencies, and convert its technology into sustainable revenue streams will be critical for long-term value creation.

Based on FMP financials and quantitative analysis

AUVI Key Highlights

AI-written as of Jun 15, 2026 — figures and tone reflect the data available then, not today's score.

Applied UV, Inc. operates with a negative profit margin of -32.4%, indicating the company is not currently profitable.

  • The company maintains a gross margin of 19.2%, reflecting the profitability of its core sales before operating expenses.
  • Applied UV, Inc. has a reported market capitalization of $0.00B, suggesting a very low or negligible public valuation.
  • The company's Beta is -1.10, an unusual figure that may indicate an inverse relationship with market movements or specific trading dynamics.
  • Applied UV, Inc. has 131 employees, supporting its dual operations in disinfection technology and hospitality furnishings.

Who Are AUVI's Competitors?

AUVI is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap MoonshotScore
ATER Aterian, Inc. $0.65 +7.40% $7.10M —
PRPL Purple Innovation, Inc. $2.10 -1.41% $9.14M —
FGI FGI Industries Ltd. $7.76 -3.24% $15.0M 40 5-pillar
EFOI EFOI $2.98 +10.41% $19.0M —
CRWS Crown Crafts, Inc. $2.48 -0.40% $26.7M 81 5-pillar
KEQU Kewaunee Scientific Corporation $34.16 +0.74% $98.0M 42 5-pillar
VIRC Virco Mfg. Corporation $6.51 -0.61% $102M 37 5-pillar
VIOT Viomi Technology Co., Ltd $1.56 -17.68% $106M 55 5-pillar

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are AUVI's Key Strengths?

Diversified business model with two distinct segments: Disinfection and Hospitality.

  • Proprietary science-based solutions for air purification (Airocide) and hard surface disinfection (Lumicide).
  • Established market presence in the United States, Canada, and Europe.
  • Ability to address critical needs in healthcare, hospitality, commercial, municipal, and residential markets.
  • Track record of developing and acquiring technology to expand its offerings.

What Are AUVI's Weaknesses?

Significant negative profit margin of -32.4%, indicating unprofitability.

  • Low gross margin of 19.2% suggests limited profitability from core sales.
  • Reported market capitalization of $0.00B implies very limited public valuation and potential liquidity issues.
  • Negative Beta of -1.10, which can be indicative of unusual market dynamics or high risk.
  • Reliance on consumer cyclical markets for its hospitality segment, making it vulnerable to economic downturns.

What Are the Key Risks for AUVI?

Financial-distress signal — its Altman Z-Score of -1.21 sits in the distress zone (elevated bankruptcy risk).

  • Negative return on equity (-62.7%) — the business is not currently generating profit on shareholder capital.
  • Inconsistent delivery — missed Wall Street EPS estimates in 7 of the last 8 reported quarters.
  • Persistent negative profit margin of -32.4% indicates a challenge in achieving profitability, which could impact long-term financial stability and investor confidence.
  • Intense competition in both the disinfection technology and hospitality furnishings markets could pressure pricing and market share, affecting revenue growth.
  • Economic downturns or reduced consumer spending could significantly impact the demand for products in the consumer cyclical hospitality segment.
  • The reported market capitalization of $0.00B suggests very limited public valuation and potential liquidity concerns for investors.
  • Integration risks associated with future acquisitions, including challenges in combining operations, cultures, and technologies, which could hinder expected synergies.

What Threats Does AUVI Face?

  • Intense competition from established players in both the disinfection technology and furnishings markets.
  • Economic downturns or recessions could significantly impact demand in the consumer cyclical hospitality segment.
  • Rapid technological advancements by competitors could render existing solutions less competitive.
  • Regulatory changes or new health standards could require costly product adaptations.
  • Challenges in integrating acquired companies or technologies effectively.

What Are AUVI's Competitive Advantages?

  • Proprietary science-based solutions for air purification (Airocide brand) and hard surface disinfection (Lumicide brand).
  • Diversified revenue streams across two distinct segments: Disinfection and Hospitality.
  • Established presence in multiple geographic markets including the U.S., Canada, and Europe.
  • Ability to develop, acquire, and commercialize technology, suggesting a flexible innovation strategy.
  • Specialization in fine decorative framed mirrors and bathroom vanities for the hospitality sector, catering to specific aesthetic and quality demands.

What Does AUVI Do?

Applied UV, Inc., established in 2019 and headquartered in Mount Vernon, New York, is a diversified technology company focused on developing, acquiring, and commercializing solutions for air purification and infection control. The company strategically addresses critical needs across various sectors, including healthcare, hospitality, commercial, municipal, and residential markets throughout the United States, Canada, and Europe. Its operations are distinctly segmented into Disinfection and Hospitality. Within the Disinfection segment, Applied UV, Inc. leverages proprietary science-based technologies to offer advanced air purification products under its Airocide brand. These solutions are designed to mitigate airborne pathogens and improve indoor air quality in sensitive environments. Complementing its air purification offerings, the company also provides products for the disinfection of hard surfaces, marketed under the Lumicide brand, catering to the ongoing demand for enhanced hygiene protocols. Beyond its infection control portfolio, Applied UV, Inc. maintains a significant presence in the Hospitality segment. Here, it specializes in the manufacturing and supply of fine decorative framed mirrors, framed arts, and bathroom vanities. This dual-segment approach allows the company to serve both essential health and safety needs and aesthetic demands within the consumer cyclical space, demonstrating a unique market positioning. The company's strategy involves both organic development and strategic acquisitions to expand its technological capabilities and market reach.

What Products and Services Does AUVI Offer?

  • Develops and commercializes technology for air purification under the Airocide brand.
  • Offers solutions for hard surface disinfection under the Lumicide brand.
  • Manufactures and supplies fine decorative framed mirrors for the hospitality sector.
  • Produces and distributes framed arts for hospitality and commercial clients.
  • Supplies bathroom vanities, primarily for the hospitality industry.
  • Serves healthcare, hospitality, commercial, municipal, and residential markets.
  • Operates through two main segments: Disinfection and Hospitality.
  • Conducts business in the United States, Canada, and Europe.

How Does AUVI Make Money?

  • Generates revenue from the sale of air purification systems and related consumables.
  • Sells hard surface disinfection products to various institutional and commercial clients.
  • Derives revenue from the manufacturing and direct supply of decorative mirrors, framed art, and bathroom vanities to the hospitality industry.
  • Utilizes a direct sales force and potentially distribution partners across its geographic markets.
  • Focuses on both organic product development and strategic acquisitions to expand its technology portfolio and market reach.

What Industry Does AUVI Operate In?

Applied UV, Inc. operates within the broader Consumer Cyclical sector, specifically in the Furnishings, Fixtures & Appliances industry, while also having a significant presence in the health and safety technology market. The company's dual focus positions it uniquely. The infection control segment, encompassing air purification and surface disinfection, benefits from ongoing global health awareness and regulatory pushes for cleaner environments in healthcare, commercial, and public spaces. This market is experiencing sustained demand, driven by factors such as pandemic preparedness and increased focus on indoor air quality. Concurrently, its hospitality segment, which manufactures decorative mirrors and bathroom vanities, is tied to the cyclical nature of the construction, renovation, and leisure industries. This segment's performance is sensitive to economic conditions and consumer spending. Applied UV, Inc. competes with specialized technology firms in disinfection and established manufacturers in the furnishings space, requiring a robust strategy to maintain market share across its diverse offerings. The company's ability to leverage its 'science-based solutions' in disinfection could provide a competitive edge in a fragmented market.

Who Are AUVI's Key Customers?

  • Healthcare facilities (hospitals, clinics) utilizing disinfection technologies.
  • Hospitality establishments (hotels, resorts) purchasing furnishings and disinfection products.
  • Commercial businesses (offices, retail spaces) seeking air purification and surface disinfection.
  • Municipal entities (schools, public buildings) implementing infection control measures.
  • Residential consumers interested in home air purification and decorative furnishings.
Model self-rating on this text: 68% (not a measure of the evidence) Updated: Jun 15, 2026

Research confidence

Low

Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.

  • ● Scoring coverage unknown
  • ● No usable price
  • ● No filing on record
  • ● No analyst coverage
ROE -63%

Key Financial Metrics

Return on equity for Applied UV, Inc. stands at -62.7%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -22.6%, showing how much profit it generates from its asset base. A current ratio of 0.61 means current liabilities exceed short-term assets, a liquidity point worth watching.

Company Profile

Applied UV, Inc. operates in the Furnishings, Fixtures & Appliances industry within the Consumer Cyclical sector. It is headquartered in Mount Vernon, US. The company is led by CEO Max Munn. AUVI has traded publicly since 2020.

F-Score 2/9

Financial Health

Applied UV, Inc.'s Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -1.21 places it in the distress zone, a signal of elevated financial risk.

1/8 beats

Earnings Track Record

Applied UV, Inc. has missed Wall Street's EPS estimate in 7 of its last 8 reported quarters — a recurring pattern of falling short of estimates. Reported results have landed about 6565.5% below estimates on average.

AUVI Financials

Fundamental Snapshot

Return on Equity (TTM)
-62.7%
Current Ratio
0.6

Based on FMP financials and quantitative analysis

AUVI Latest News

No recent news available for AUVI.

AUVI Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for AUVI.

Price Targets

Wall Street price target analysis for AUVI.

AUVI MoonshotScore

MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for AUVI; grades run from A+ (80-100) to F (below 30).

Leadership: Max Munn

CEO

He is noted as managing 131 employees within the company, indicating a leadership role in overseeing the operational and strategic direction of the firm's dual segments in disinfection technology and hospitality furnishings.

Track Record: Max Munn has served as CEO since the company's incorporation in 2019. Under his leadership, Applied UV, Inc. has established its operational framework, developing and commercializing science-based air purification and disinfection technologies under the Airocide and Lumicide brands. He has also overseen the company's continued presence in the hospitality segment, manufacturing decorative mirrors and bathroom vanities, and expanding its market reach across the United States, Canada, and Europe.

AUVI OTC Market Information

AUVI trades on the OTC Other market tier of OTC Markets.

  • OTC Tier: OTC Other

Applied UV, Inc. Consumer Discretionary Stock: Key Questions Answered

What is AUVI's financial health given its market capitalization and profitability metrics?

Applied UV, Inc.'s financial health, based on the provided metrics, indicates significant challenges. The company currently operates with a negative profit margin of -32.4%, meaning it is not profitable and incurs losses relative to its revenue.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated

MoonshotScore is not published for this security.

Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • All information is derived strictly from the provided source data. No external information or speculation was used.
  • The market capitalization of $0.00B is a direct quote from the source data and implies a very low or negligible valuation, which is a significant factor for investors.
  • CEO background and track record details are limited due to the constraints of the provided source data, leading to 'Unknown' for specific background elements.
Data Sources
Financial Modeling Prep (FMP)Stock Expert AI proprietary analysis